Zobrazeno 1 - 10
of 238
pro vyhledávání: '"SHIGEO YAMAGUCHI"'
Autor:
Yuko Uchida, Masaji Mase, Kumiko Yoneda, Atsumu Kimura, Tsuyoshi Obara, Seikou Kumagai, Takehiko Saito, Yu Yamamoto, Kikuyasu Nakamura, Kenji Tsukamoto, Shigeo Yamaguchi
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 9, Pp 1427-1429 (2008)
On April 21, 2008, four whooper swans were found dead at Lake Towada, Akita prefecture, Japan. Highly pathogenic avian influenza virus of the H5N1 subtype was isolated from specimens of the affected birds. The hemagglutinin (HA) gene of the isolate b
Externí odkaz:
https://doaj.org/article/6a72883d777e403fad23b8329aa388a8
Autor:
Satoko Nakano, Akemi Mibu, Shunsuke Kato, Shigeo Yamaguchi, Yuna Suzuki, Kaoru Tanimura, Masataka Sano
Publikováno v:
Journal of Nippon Medical School. 90:179-185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f76e5c04aa870bc677615f42a7bd8142
https://doi.org/10.1272/jnms.jnms.2023_90-205
https://doi.org/10.1272/jnms.jnms.2023_90-205
Autor:
MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO, SHUNSUKE KATO
Publikováno v:
Anticancer Research. 42:2277-2288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::153754b565e42950f05f8bcfd411cf63
https://doi.org/10.21873/anticanres.15707
https://doi.org/10.21873/anticanres.15707
Autor:
Shigeo Yamaguchi, Satoko Nakano, Shunsuke Kato, Masataka Sano, Yoshimi Imawari, Akemi Mibu, Masahiko Otsuka
Publikováno v:
Journal of Nippon Medical School. 89:88-94
Background The emergence of molecular targeted therapies (MTTs) has altered the treatment landscape of hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (MBC). The objective of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcccc876a33e27289dcf1da4d2be6b42
https://doi.org/10.1272/jnms.jnms.2022_89-203
https://doi.org/10.1272/jnms.jnms.2022_89-203
Autor:
Shun-ichiro Kageyama, Atsushi Motegi, Junyan Du, Riu Yamashita, Hidehiro Hojo, Masaki Nakamura, Ryuji Hamamoto, Tetsuo Akimoto, Syuzo Kaneko, Katsuya Tsuchihara, Shigeo Yamaguchi, Masayuki Okumura
Publikováno v:
Radiotherapy and Oncology. 155:10-16
Background and purpose Ionising radiation causes mutations in the genomes of tumour cells and serves as a potent treatment for cancer. However, the mutation signatures in the cancer genome following ionising radiation have not been documented. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be81c9f6a093c84b05a4f62729b9cca
https://doi.org/10.1016/j.radonc.2020.10.020
https://doi.org/10.1016/j.radonc.2020.10.020
Autor:
Mai Onishi, Shigeo Yamaguchi, Xuan Wen, Min Han, Hidenori Kido, Tomoyuki Aruga, Shin-ichiro Horiguchi, Shunsuke Kato
Purpose Triple-negative breast cancer (TNBC) is considered a heterogeneous population and achieving a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is an only prognostic factor. Previously, the TP53 signature (TP53sig)-score,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f654fb987de03515491b5fea2267fda6
https://doi.org/10.21203/rs.3.rs-1233460/v1
https://doi.org/10.21203/rs.3.rs-1233460/v1
Publikováno v:
Cancer Science
Because of the complexity of cancer‐immune system interactions, combinations of biomarkers will be required for predicting individual patient responses to treatment and for monitoring combination strategies to overcome treatment resistance. To this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8efbc9383895d7b86bbbd7fba29666
http://europepmc.org/articles/PMC7648030
http://europepmc.org/articles/PMC7648030
Autor:
Ayako Nakashoji, Yuko Kawai, Tetsu Hayashida, Kazuhiro Miyao, Rurina Watanuki, Yuko Kitagawa, Takamichi Yokoe, Tomoko Seki, Maiko Takahashi, Shigeo Yamaguchi, Masayuki Kikuchi
Publikováno v:
Journal of Oncology, Vol 2020 (2020)
First identified as a developmental gene, HOXB9 is also known to be involved in tumor biological processes, and its aberrant expression correlates with poor prognosis of various cancers. In this study, we isolated a homeodomain-less, novel HOXB9 vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391f4245888b187db70cbcd694365252
https://doi.org/10.1155/2020/6065736
https://doi.org/10.1155/2020/6065736
Autor:
Min, Han, Shigeo, Yamaguchi, Mai, Onishi, Tomoaki, Fujii, Masaki, Hosoya, Xuan, Wen, Hidenori, Kido, Shunsuke, Kato
Publikováno v:
Anticancer research. 42(5)
The TP53-signature is a multi-gene signature that can predict TP53 structural mutations. It has presented remarkable ability to predict the prognosis of early-stage breast cancer. However, some samples presented discordance with the signature status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf9a804064d5481e65efe9456f13dd52
https://pubmed.ncbi.nlm.nih.gov/35489754
https://pubmed.ncbi.nlm.nih.gov/35489754
Autor:
Shota Hoshino, Satoru Matsuda, Hirofumi Kawakubo, Shigeo Yamaguchi, Kohei Nakamura, Eriko Aimono, Kazuaki Matsui, Tomoyuki Irino, Kazumasa Fukuda, Rieko Nakamura, Hajime Okita, Hiroshi Nishihara, Hiroya Takeuchi, Yuko Kitagawa
Publikováno v:
Annals of surgical oncology. 29(11)
Despite previous reports on the clinical significance of plasma fibrinogen (FNG) levels as a prognostic indicator of ESCC, its underlying mechanism remains unclear. This study aimed to validate the prognostic impact of plasma FNG levels and clarify i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66df9fed08d6fcbc7abb97a8b7f9e7bc
https://pubmed.ncbi.nlm.nih.gov/35717519
https://pubmed.ncbi.nlm.nih.gov/35717519